RDHL Should I Buy

Redhill Biopharma Ltd (RDHL) is not a strong buy for a beginner investor with a long-term strategy at this moment. The lack of clear technical signals, no recent news or catalysts, and neutral trading trends suggest limited upside potential in the short term. Additionally, the stock's historical trend indicates a higher probability of near-term decline, which does not align with the user's impatience for optimal entry points.

The MACD is slightly positive but contracting, indicating weakening momentum. The RSI is neutral at 62.221, and moving averages are converging, showing no clear trend. The stock is trading near its resistance level (R1: 1.372), which might limit immediate upward movement. Historical trends suggest a 40% chance of a -2.52% decline in the next day and a -5.09% decline in the next week.